Pharmaceutical company Pfizer’s animal health division posted third-quarter 2007 revenues of US$636 million, a 13% increase in comparison to US$562 million in the same period last year.
For the first nine months of 2007, revenues increased 12% to US$1.9 billion compared to US$1.7 billion in the same period last year.
The increase in both periods is largely attributed to strong product performance in the companion animal and international livestock businesses; the acquisition of Embrex, a company with a unique vaccine delivery system that vaccinates chicks while inside their eggs; and the favourable impact of foreign exchange.
The results were made public in a company press release.
Pfizer as a total posted third-quarter 2007 revenues of US$12.0 billion, a 2% decline from the same period last year.